Tarantino R, Bishop E, Chen F C, Iqbal K, Malick A W
Hoffmann-La Roche, Inc., Nutley, NJ 07110.
J Pharm Sci. 1994 Sep;83(9):1213-6. doi: 10.1002/jps.2600830905.
N-Methyl-2-pyrrolidone (methylpyrrolidone), a cosolvent which has been used in veterinary medicine and in transdermal delivery devices, was investigated as a cosolvent for model drug compounds of widely varying polarity. These compounds were digoxin, sulfamethoxazole, hydrocortisone acetate, theophylline, phenytoin, and reserpine. Methylpyrrolidone was found to be an extremely efficient cosolvent for low solubility polar drugs such as digoxin or drugs containing multiple proton-donating groups such as phenytoin. The increase in solubility observed in aqueous solutions of digoxin and phenytoin to which 0.2 volume fraction of methylpyrrolidone was added was 500x and 65x, respectively. Significant deviations from log-linear solubilization were observed with digoxin, sulfamethoxazole, phenytoin, and reserpine, indicating significant water-solute-cosolvent interactions.
N-甲基-2-吡咯烷酮(甲基吡咯烷酮)是一种已用于兽医学和透皮给药装置的助溶剂,本研究将其作为极性差异很大的模型药物化合物的助溶剂。这些化合物包括地高辛、磺胺甲恶唑、醋酸氢化可的松、茶碱、苯妥英和利血平。结果发现,甲基吡咯烷酮对于低溶解度的极性药物(如地高辛)或含有多个质子供体基团的药物(如苯妥英)是一种极其有效的助溶剂。在添加了0.2体积分数甲基吡咯烷酮的地高辛和苯妥英水溶液中,观察到的溶解度增加分别为500倍和65倍。地高辛、磺胺甲恶唑、苯妥英和利血平的溶解情况明显偏离对数线性关系,表明存在显著的水-溶质-助溶剂相互作用。